Cancer Gene Therapy Market by Therapy and Geography - Forecast and Analysis 2021-2025

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Five Forces Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Therapy

• Market segments
• Comparison by Therapy
• Oncolytic virotherapy - Market size and forecast 2020-2025
• Gene transfer - Market size and forecast 2020-2025
• Gene-induced immunotherapy - Market size and forecast 2020-2025
• Market opportunity by Therapy

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Volume drivers – Demand led growth
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Adaptimmune Therapeutics plc
• Advantagene Inc.
• Amgen Inc.
• Anchiano Therapeutics Ltd.
• bluebird bio Inc.
• GlaxoSmithKline Plc
• Merck KGaA
• Shanghai Sunway Biotech Co. Ltd.
• Sibiono GeneTech Co. Ltd. Shenzhen (Sibiono)
• ZIOPHARM Oncology Inc. 

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations